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We present a dual-stage neural network architecture for analyzing fine shape details from microscopy
recordings in 3D. The system, tested on red blood cells, uses training data from both healthy donors
and patients with a congenital blood disease. Characteristic shape features are revealed from the
spherical harmonics spectrum of each cell and are automatically processed to create a reproducible
and unbiased shape recognition and classification for diagnostic and theragnostic use.
I. MAIN
Cell morphology is a phenotypic characteristic reflecting
the cell cycle, metabolic state or cellular activity [1–3].
While brightfield imaging is affected by the orientation of
cells on the microscopy slide, which determines a certain
projection, 3D confocal microscopy allows to investigate
the whole cell surface without loss of information.
The analysis of shapes is related to feature detection in
processed images. Deep-learning-based approaches can
potentially be employed for such tasks, avoiding man-
ual procedures that are time consuming, subjective and
prone to human error. For this reason, we developed a
method that provides recognition at high shape-detail
resolution of 3D objects that are similar in shape and
nature, thus having the potential to be universally used
due to its precision. This method is implemented with a
low computational cost.
To evaluate our system, we employed red blood cells
(RBCs), representing one the most deformable cell types.
In healthy subjects, RBCs in stasis are typically biconcave
disks, but external factors such as the pH or osmolarity of
the suspension medium or interaction with surfaces can
stimulate a shape transition. Such transformations appear
in a distinct order and are described as the stomatocyte-
discocyte-echinocyte (SDE) sequence [4]. In case of blood
diseases, additional morphological abnormalities appear,
defining certain blood disorders (e.g., hereditary spherocy-
tosis, sickle cell disease, acanthocytosis or stomatocytosis)
[5, 6]. The investigation of RBC morphology for the
diagnosis of hematological diseases relies on the visual
examination of blood smears. Advances in automation of
the analysis have especially involved convolutional neural
networks (CNNs) for white blood cell recognition [7] and,
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in some cases, for RBC detection and shape classification
in 2D, both in stasis and flow [8–10]. However, in blood
smear preparation the smearing and drying procedures
affect cells, leading to unwanted morphological deforma-
tion [11] and loss of the 3D information of the original
cell shape.
Instead of this technique, we performed fixation of RBCs,
followed by fluorescent staining. Confocal microscopy was
used to capture the 3D representations of cells by means
of z-stacks (Fig. 1a). After offset elimination, intensity
normalization and adaptation of the resolution in the x/y
and z direction by interpolation (Fig. 1b), we discrim-
inated the cell membrane as an isosurface defined by a
constant intensity threshold (Fig. 1c). In contrast to pre-
existing classification approaches for such kinds of data,
e.g., 3D-CNNs [12] or voxelwise processing techniques
[13], we transformed and subsequently collapsed the volu-
metric data to exclusively access the features of interest.
This data reduction was achieved by decomposing the
spatial information of the cell surface into the respective
spherical harmonics (SH) spectrum (Fig. 1d) [14]. Thus,
a one-dimensional data-vector was obtained, encoding
the prevalent features of the 3D shape and characterized
by rotation and translation invariance (see Methods). A
subsequent normalization mapped the SH spectrum into
the range from 0 to 1, rendering the data suitable to train
artificial neural networks (ANNs).
For cell shape recognition, we used a dual-stage ANN
architecture (Fig. 1e). The first stage was designed to
sort out distinct RBC shapes that do not fit the SDE
spectrum. Such shapes particularly occur in samples from
patients with blood diseases or other pathologies [5, 6].
An additional class of “unknown” cells was added to reflect
human uncertainty regarding unclear or rare shapes not
yet defined in the literature. This class included all cells
classified by the first-stage ANN with an identification
accuracy below a threshold of 75%.
The second stage served to discriminate all SDE shapes.
Previously, the SDE sequence was described by assigning
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2different shapes to pseudodiscrete classes, such as sphero-
cytes, stomatocytes type I/II, discocytes and echinocytes
type I/II/III, to serve as reasonable support for manual
classification [4]. By employing supervised training for
both ANNs, we used the state-of-the art classification
scheme to create training data for carefully selected sets
of non-SDE (Fig. 1g) and ideal SDE (Fig. 1h) shapes.
In between the pseudodiscrete SDE classes, extra transi-
tion shapes were observed. For this reason, we assumed
that the shape transformation occurs in a continuous
manner and introduced a linear scale to automatically as-
sign any identified SDE shape to an interval ranging from
−1 (spherocytes) over 0 (discocytes) to +1 (echinocytes).
The regression-type ANN of the second stage allowed for
fine distinction of morphological details within the whole
spectrum at a precision that is manually unattainable.
The overall system consisted of (1) a classification-type
ANN, which assigns each cell to one out of seven types
(SDE shapes, knizocytes, keratocytes, acanthocytes, mul-
tilobate cells, cell clusters and unknown cells, Fig. 1f top),
followed by (2) a regression-type ANN, which character-
izes all detected SDE shapes (spherocytes, stomatocytes
type II/I, discocytes and echinocytes type I/II/III, Fig.
1f bottom).
The need for a vast amount of data for both training and
validation was met by exhaustive augmentation. This
was performed by selecting random pairs of cell shapes
followed by random superposition and normalization of
their spectra. In particular, we created artificial data
within each of the mutually exclusive classes for the first-
stage ANN as well as random interpolations between
neighboring or the same SDE pseudodiscrete classes for
the second-stage ANN. Avoiding a dependency between
training and validation data, the split was performed
before interpolation (for training and validation loss and
accuracy see Supplementary Fig. 1 and 2).
Our system was validated through the inspection of blood
samples from 10 healthy donors (Supplementary Fig. 3),
where a prevalence in discocytes is expected. Then, the
method was tested on 10 patients with the most commonly
mutated genes causing hereditary spherocytosis (SLC4A1,
ANK1, Fig. 2, Supplementary Note and Supplementary
Table 1). As highlighted in a confusion matrix created
for healthy controls and patients (Supplementary Fig. 4),
the comparison of manual classification and automatic
classification (first-stage ANN) resulted in a variable mis-
match due to the rare occurrence of related shapes in
blood samples and limited available training data. On
the other hand, we observed a high agreement between
the automatic allocation of cells on the SDE scale (second
stage), ranging from 78% to 100%.
From a clinical perspective, patients’ data resulted in a
different statistical output compared to those of healthy
donors (Fig. 1f and Supplementary Fig. 3), with wider
shape distributions within the SDE scale and an expected
value toward stomatocytes for P5 and P8 (Fig. 2). The
tendency of RBCs to form a round shape is a hallmark of
hereditary spherocytosis, and spherocytes are particularly
expected in blood smears of affected subjects. A previous
study reported that 2.6% of blood smears in a set of 300
patients did not exhibit detectable spherocytes, leading to
a possible misdiagnosis [15]. However, the evaluation in
3D indicated that spherocytes in the tested set of patients
were very rare or completely absent and comparable in
number to those found in healthy subjects. These results
confirmed the dependence of blood smear shape analysis
on cell rotation (Fig. 2, Supplementary Fig. 5), proving
that spherocytes are not the main shape in hereditary
spherocytosis.
Some indications of the presence of other shape defor-
mations in blood smears were reported [16, 17] and may
have an association with the different genetic mutations
causing the disease. The fine recognition of shape details
by the automated dual-stage ANN resulted in a differen-
tial shape profile for various mutations. This represents
additional information compared to that obtained from
blood smears, where solely the type of blood disease can
be discriminated. Finally, the prevalence of shapes oc-
curring in non-SDE classes, especially in the unknown
class, underlined the high morphological variability in
patients, highlighting the demand for further RBC shape
definitions.
In conclusion, the proposed approach describes an au-
tomated evaluation system for cell morphology in addi-
tion to or instead of manual methods. Its application in
hematology revealed that conventional microscopy has
limitations with regard to cell morphology that may lead
to erroneous interpretations and shows the superiority of
3D visualization and characterization of cell shapes. In
addition to the unbiased outcome, automation by ANN
allowed both the recognition of small shape details and
the possibility of using a regression-based approach for
cells undergoing continuous shape transitions. Owing
to the details revealed using 3D imaging combined with
ANNs as a universal tool for shape recognition, thorough
tests on anemic subjects may render our method suitable
for diagnostic purposes. In addition, from the results
obtained with the tested pool of patients, we observed
potential applicability with larger datasets to relate the
ANN output to a particular mutation. While genetic anal-
ysis is the gold standard for detection, cell imaging can be
of additional interest in the investigation of the severity
and state of a disease [18]. Moreover, it can be applied
for personalized theragnostics when the effectiveness of
a specific treatment is tracked [19]. Our method may
be adapted for other cell biological applications or even
industrial purposes.
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Figure 1. Workflow for automatic classification by the dual-stage ANN. a After sample staining and imaging by
confocal microscopy, each cell is cropped individually and the full stack is interpolated in the z direction to achieve isotropic
resolution (b). c The isosurface is retrieved by applying a constant threshold to each cell. d The vectorized data are transformed
with respect to their spherical harmonics (L2-norm of 32 radii and corresponding 16 frequencies, see Methods), representing a
rotation invariant form of the cell shape. e Data are fed to the dual-stage ANN, with the first-stage resulting in a classification
output (bottom). This stage consists of a three-layer architecture providing an input layer (544 neurons), a fully connected
hidden layer with a ReLU activation function (54 neurons) and a fully connected output layer (softmax activation). The output
is represented by a vector of size 7, which is subjected to discrimination by a given threshold. If the confidence is higher than
75% (threshold), the output is assigned to a certain existing class. Otherwise, the output is assigned to unknown (U) shapes.
All detected SDE shapes are forwarded to the second-stage ANN, with an anatomy similar to that of the first ANN, except for
the hidden layer that exhibits 544 neurons. The regression-type output layer assigns each cell a score between −1 and +1 and
allocates them on the continuous SDE scale (top). f Example of a typical resulting shape distribution in a healthy subject.
Almost all RBCs are discocytes. g Representative images for 6 mutually exclusive shape classes (see Methods for description):
two out of many different examples of unknown shapes are shown. h Representative cells of the SDE scale. The training data
included SDE shapes artificially induced by changing the osmolarity of the suspension medium.
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Figure 2. Automatic 3D RBC shape recognition for patients affected by hereditary spherocytosis. The total
number of cells analyzed in both the classification and SDE distribution per patient are indicated. The probability density
distributions within the SDE range show the expected value µ (dashed red line) and highlight 95% confidence intervals (dark
gray area). The results demonstrate that most of the patients have expected values related to discocytes, with a tendency toward
stomatocytes. A population of spherocytes (score −1) is lacking in all 10 samples, proving that such a shape is not a hallmark
of the disease. Additionally, shape profiles among patients are different, suggesting a relation to the various genetic mutations
(SLC4A1, and in one case ANK1 ). In particular, P1 and P2 as well as P3 and P4 (nonidentified mutation) are relatives and
show similar profiles, especially within the SDE range. P5 harbors a mutation that affects the cytoskeletal protein ankyrin,
resulting in the highest number of stomatocytes, including some spherocytes. P6, P7 and P9 are affected by mutations in the
band 3 protein, as is P8, who also has a double mutation in spectrin alpha (see Supplementary Table 1), although this latter
mutation is not known to be pathogenic. The differences among these patients may depend on the particular mutation altering
the same gene: P6 showed 21% acanthocytes, which occur in variable numbers in P1 and P2, P7 and P9. The phenotypic
associated defect in fact, in some cases, causes band 3 deficiency, while in others, it leads to spectrin deficiency (Supplementary
Table 1). Other classes showed rare occurrences, and shape deviations were classified as unknown cells in all the tested samples,
suggesting that a larger amount of shape deformations were detected by the ANNs.
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Methods
I. SAMPLE PREPARATION FOR TRAINING
DATA GENERATION
Blood was drawn with informed consent from 5
healthy donors via finger prick blood sampling in
tubes containing 5µl of 1.6mg/ml EDTA. RBC shape
transitions within the SDE scale were induced by os-
molarity variation of the suspension solution (Sup-
plementary Fig. 6). Ten microliters of each sample
was resuspended in 1ml of NaCl solutions of differ-
ent concentrations: 0.9 % NaCl was used to preserve
discocyte shapes and 0.4% NaCl was used to induce
spherostomatocytes formation. Intermediate shapes
were obtained by suspending cells in 0.5% NaCl (stom-
atocyte types I and II) and 2.5% NaCl (echinocyte
types I and II) solutions (for echinocyte type III, see
below).
A total of 400µl of each cell suspension was fixed
in 1ml of 1% glutaraldehyde (Sigma-Aldrich, Saint
Louis, USA) solution in NaCl. To fix cells with the
desired shape, each glutaraldehyde solution was pre-
pared to have a total osmolarity equal to the osmolar-
ity of the NaCl solution used to induce each shape [1].
Fixed cells were placed in a rotator mixer (Grant-bio
PTR-35, Grant Instruments, Cambridge, England)
at room temperature overnight. Samples were later
centrifuged at 4000 g for 5 minutes (Eppendorf Mi-
cro Centrifuge 5415 C, Brinkmann Instruments, NY,
USA), washed 3 times with 1ml of each respective
NaCl solution used to induce the different shapes and
eventually resuspended in 1ml of the same solution.
Five microliters of CellMask™Deep Red plasma mem-
brane stain 0.5mg/ml (Thermo Fisher Scientific, Ore-
gon, USA) was added to each sample for 24 hours at
room temperature.
Then, the cells were washed 3 times as described pre-
viously. Echinocyte type III was formed with live cells
by exploiting the glass effect. First, 10µl of blood
was suspended in 1ml of PBS and labeled with Cell-
Mask™Deep Red. After washing, the cells were re-
suspended in PBS and finally placed on a glass slide
for confocal microscopy. For later testing, 5µl of fresh
blood drawn by finger pricks from 10 volunteers and
10 patients with hereditary spherocytosis was fixed
in 1ml of either 1% or 0.1% glutaraldehyde in PBS,
stained as described above and imaged. Samples from
patients were fixed and shipped from Fondazione IR-
CCS Ca’ Granda Ospedale Maggiore Policlinico of
Milan (Italy) and University Medical Center Utrecht
(The Netherlands).
II. IMAGING BY CONFOCAL MICROSCOPY
Each labeled sample was placed between two glass
slides for imaging (VWR rectangular coverglass, 24×
60mm) on top of a 60X objective (CFI Plan Apoc-
hromat Lambda 60X Oil, NA = 1.4, Nikon, Tokyo,
Japan) of an inverted microscope (Nikon Eclipse Ti).
A solid-state laser (λ = 647 nm, Nikon LU-NV Laser
Unit) was used as a light source for imaging. Z-stack
scanning was realized by employing a 300nm piezo
stepper for a 20µm z-range. Confocal image gener-
ation was performed with a spinning-disk based con-
focal head (CSU-W1, Yokogawa Electric Corporation,
Tokyo, Japan). Image sequences were acquired with a
digital camera (Orca-Flash 4.0, Hamamatsu Photon-
ics, Hamamatsu City, Japan).
III. IMAGE PREPROCESSING
A custom written MATLAB™(MathWorks, MA,
USA) routine was used to crop single cells from each
image and perform their 3D reconstruction to enable
visualization of the 3D shape. Each single-cell 3D
image contained 68 individual planes with an extent
of 100px × 100px and a lateral (x/y) resolution of
0.11µm/px. The piezo stepper had a minimal step
width of 0.3µm, defining the z-resolution accordingly.
To compensate for the difference in resolution in the
x/y and z directions, we adapted the scale in z by
means of linear interpolation. Thus, the obtained z-
stack had dimensions of 100 px×100px×185px. The
image stacks were then passed to a custom written
ImageJ script. By applying a fixed threshold for ev-
ery image, the script binarized the confocal z-stack to
retrieve the cell membrane as an isosurface. After vec-
torization, the origin of the cell always corresponded
to the center of its bounding box. Therefore, this step
had the benefit of introducing an inherent translation
invariance, i.e., for a given rotation, the form and size
of the bounding box is invariant regarding translations
in space. The obj-files (Wavefront Technologies, CA,
USA) generated in such a manner were then automat-
ically transformed into the polygon file format (ply)
and passed to the shape descriptor for the spherical
harmonics analysis.
IV. SPHERICAL HARMONICS ANALYSIS
The spherical harmonics analysis was performed by
using the high-performance software implementation
described by Kazhdan et al. [2]. The algorithm first
maps a given 3D object (ply format) onto a 3D voxel
grid of defined size. For our purpose, we kept the stan-
dard parameters of the algorithm, using a voxel grid
of 64px× 64px× 64px. Within this cube, at least 32
spherical functions of different radii can be arranged
around the center point. Each spherical function can
then be decomposed as the sum of its harmonics:
ar
X
iv
:2
00
5.
08
04
0v
1 
 [q
-b
io.
QM
]  1
6 M
ay
 20
20
2f (Θ, φ) =
∞∑
l=0
m=l∑
m=−l
almY
m
l (Θ, φ) (1)
Keeping the standard settings, for every radius, 16
frequencies (harmonics) were calculated. In addition,
the first- and second-order components of each decom-
position were expressed in a Euclidean manner using
3 scalars a1, a2, a3:
f0 + f2 = a1x2 + a2y2 + a3z2. (2)
In the case of principal component analysis (PCA),
these values could potentially be used for alignment
purposes. However, in our case, these factors were
not employed for further PCA investigations but were
included in the training process. After transforma-
tion, each frequency component was accumulated by
calculating the corresponding L2-norm. This resulted
in a vector of size 32 × (3 + 14) = 544, where 32
corresponded to the number of radii, 3 to the scalars
describing f0 and f2, and 14 to the number of remain-
ing frequencies for each radius. Finally, each cell was
expressed by means of a one-dimensional vector. For
further signal processing, this vector was normalized
and mapped onto a numeric range from 0 to 1. The
intrinsic rotation invariance with respect to the origi-
nal 3D data was the key factor in choosing this kind of
transformation for shape description. This is because
cells can have any orientation after sedimentation on
the microscopy slide, and a general expression of their
shape is required for further analysis.
V. MANUAL CLASSIFICATION
Each vectorized cell was rendered using Blender
for cell shape visualization to perform a manual
shape classification. The samples fixed in solutions
at different osmolarities were used to classify the
various shapes of the SDE scale based on Bessis’
criteria [3, 4]: (1) discocytes, meaning biconcave
and symmetric disks; (2) stomatocytes type I and
II, characterized by a lighter (I) and deeper (II)
monoconcavity; (3) spherocytes, i.e., spherical cells;
(4) echinocyte type I, crenated cells preserving
biconcavity; (5) echinocyte type II, cells with forming
spicules; and (6) echinocyte type III, cells with more
than 25 spikes. Following the observation of other
cell morphologies, the chosen shapes for additional
categories were knizocytes, i.e. trilobal cells resulting
from high shear stress or observed in some blood
diseases; keratocytes, a category including damaged
RBCs with variable shapes; acanthocytes, including
echinocytes with irregular spicules and/or a spherical
body; and multilobate cells, i.e., young reticulocytes.
A class for the exclusion of an artifact occurring
upon cell fixation, named cell clusters, was added.
Each class contained a minimum of 10 cells to a
maximum of 200 cells. Any other shape beyond the
chosen classes was not considered and therefore not
introduced in the training process.
VI. TRAINING AND VALIDATION OF THE
DUAL-STAGE ANN
Keras with TensorFlow as the backend was used to
build and train the dual-stage ANN. A set of repre-
sentative RBC shapes was chosen for the supervised
training of both ANN stages. Each of the selected
cells was then transformed according to the previ-
ously discussed steps. In addition, data augmentation
of the spectra was performed by creating 1000 linear
interpolations between randomly picked spectra be-
longing to the same class, in the case of the first-stage
ANN (classification) and between spectra of neighbor-
ing pseudodiscrete classes in the case of the second-
stage ANN (regression) to cover the whole SDE shape
spectrum. The augmentation also served to compen-
sate for the different number of ideal cell shapes that
were found for certain classes, ensuring a balanced
training dataset (1000 total data per class). Simi-
lar to the k-fold cross validation approach, we trained
both ANN stages with 100 different random starting
conditions, finally selecting the best-performing ANN
for each stage. The training data constituted 80 % of
the whole set of data, while the remaining 20 % was
used for ANN validation. The training was performed
in batches of 100 spectra for both ANNs, finalizing
the process at 100 and 40 epochs for the first-stage
and second-stage ANN, respectively. The related loss
functions were the crossentropy for the first and the
mean squared error (MSE) for the second ANN, while
the chosen optimizer for both was Adam [5].
VII. AUTOMATIC CLASSIFICATION OF 3D
SHAPES IN HEALTHY INDIVIDUALS AND
PATIENTS
Samples from 10 healthy subjects and 10 patients
affected by hereditary spherocytosis were automati-
cally classified by the dual-stage ANN. The number of
tested cells per sample ranged from 1000 to over 2000
cells. The results were manually verified in Blender.
Samples from 5 healthy donors and 5 patients were
chosen for the manual selection of 200 cells each for
comparison with the automatic shape recognition and
were plotted in a related confusion matrix.
VIII. BLOOD SMEAR
Five milliliters of whole blood was drawn in EDTA
anticoagulant. Thin peripheral blood smears were
set up within 4 hours from blood sampling, dried
and stained according to the May Grünwald-Giemsa
method [6]. RBC morphology and the number of
3spherocytes were independently assessed by two
laboratory experts. The number of spherocytes was
expressed as a percentage of the total number of
RBCs observed.
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1Supplementary information
Figure 1. Training and validation loss and accuracy for the first-stage ANN. a During training, the employed
loss function (crossentropy) was minimized throughout 100 epochs. b The categorical accuracy of cell classification for
the training and validation sets converged close to 100%. The validation split was 20%. c The accuracy was further
evaluated by means of a confusion matrix. “Predicted” versus “actual” (manually classified) cells demonstrate very good
concordance, ranging from 92% to 100%.
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Figure 2. Training and validation loss for the second-stage ANN. a Within 40 epochs, the mean squared error
(MSE) of the system was minimized. b Test on a representative set of 176 independent discocytes. The head of the
distribution is allocated as approximately 0.00, and the support does not extend beyond +0.33 (echinocyte type I) and
−0.33 (stomatocyte type I), thus showing the correct recognition of this set of shapes.
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Figure 3. Automatic 3D shape recognition of RBCs from 10 healthy subjects. As expected, in healthy
individuals, shape distributions are centered around discocytes (0.00), with expected values µ ranging from 0.00 to 0.09.
The 95% confidence interval (CI0.95) demonstrates that shape distributions do not involve echinocytes, except for C8,
which extends to the range of echinocytes I (+0.33). A very small amount of stomatocyte I exists in samples from most
donors. The vast majority of cells are identified as “SDE shapes” (see total number in the classification panel versus
total in the SDE distribution). The classification ANN contains a small percentage of cells classified as unknown. These
results support the reproducible outcome of the dual-stage ANN analysis of RBCs from different donors and corroborate
the differences seen between patients.
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Figure 4. Confusion matrices for healthy controls and patients with hereditary spherocytosis comparing
“predicted” and “actual” (manually classified) shape classes. SDE shapes resulted in excellent recognition
accuracy, ranging from 79% up to 100%, based on 2000 randomly picked cells from 5 healthy subjects and 5 patients
(10 donors× 200 cells) that were not included in the training process. Cells belonging to specific classes showed a higher
recognition error, partly due to the higher amount of unknown shapes, especially those occurring in patients, partly due
to the less well-defined shape features that allow us to clearly distinguish each class. The observed error in such classes
is related to the intrinsic inaccuracy of the training data.
5NOTE ON HEREDITARY SPHEROCYTOSIS AND TESTED PATIENTS
Hereditary spherocytosis is the most common hemolytic anemia in subjects of northern Eu-
ropean ethnicity. This disease is mostly inherited in an autosomal dominant manner, although
in approximately 20% of cases, inheritance is autosomal recessive or due to de novo muta-
tions [1]. The mutated genes code for RBC cytoskeletal proteins, most commonly the anion
exchanger band 3 and the cytoskeletal protein ankyrin, as well as spectrin and proteins 4.1
and 4.2. Occasionally, patients are affected by a combination of multiple mutations in these
genes. The defect mostly translates into a deficiency of the mutated protein. However, the
genetic mutation may result in the deficiency of a different protein. An example is defects in
band 3 and ankyrin occasionally causing the lack of spectrin integration in the membrane and
degradation of free spectrin molecules, resulting in spectrin deficiency ([2, 3], Supplementary
Table I). Different mutations may occur in the same gene, leading to variations in disease
severity [4].
Mutations in the abovementioned genes eventually lead to RBC membrane vesiculation that
reduces the cell surface-to-volume ratio, transforming the RBC from a discocyte to a sphere-like
shape [5]. These RBCs are named spherocytes and typically appear in blood smears as cells
with a smaller and circular projected area, devoid of the characteristic central pallor observed
in discocytes (4). Such RBCs are less deformable, resulting in a reduced lifespan, which may
eventually lead to anemia. This latter may be severe, moderate, mild or even absent when
RBC loss is balanced by enhanced erythropoiesis.
Typical complications involve splenomegaly, reticulocytosis and hemolytic anemia, which can
require exchange transfusions [6]. The only existing treatment is splenectomy, which improves
cell survival and, reduces anemia, reticulocyte count and hyperbilirubinemia, but not the pres-
ence of spherocytes. Additional prophylaxis against infections is recommended [7].
The variable symptomatology and the numerous mutations make hereditary spherocytosis a
highly heterogeneous disease. Moreover, spherocytes can be observed in other diseases [8] and
can also be present as an artifact of the blood smear technique. Therefore, establishment of
the correct diagnosis is dependent on several different tests.
For the 10 patients presented in this work, the diagnostic criteria were based on the following
evaluations: presence of chronic hemolytic anemia, RBC morphology examination on blood
smears, eosin-5’-maleimide (EMA) binding test, osmotic fragility test or altered osmotic gradi-
ent ektacytometry curve. Confirmation tests included sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) analysis of RBC membrane proteins and next-generation se-
quencing (NGS) for mutation identification. The mutations and related detected protein defects
are summarized in Table I. Patients P1 and P2 are relatives, as are P3 and P4. The latter
were diagnosed with hereditary spherocytosis, but their mutation could not be detected. All
patients were heterozygous for their main mutation. P8 was additionally found to be het-
erozygous for a point missense mutation (Supplementary Table I) and homozygous for the α
LELY low-expression alpha-spectrin variant. The missense mutation is considered a variant of
uncertain significance (VUS), similar to homozygosity for LELY, but the latter may contribute
to the eventual defective protein expression. The band 3 mutation is likely pathogenic and the
main cause of the disease.
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Figure 5. Typical RBCs from 3 patients affected by hereditary spherocytosis. Each box shows three different
rotations of the same cell; scale bar=4µm. a RBCs from a patient with a mutation affecting ankyrin-1 and the respective
blood smear in b; scale bar=10µm. While several spherocytes appear on the smear (arrows), 3D reconstructions show
different kinds of shapes. Top boxes: mutated proteins are indicated. The top right box in each panel shows a “true”
spherocyte from 3 different viewing angles. c and d are patients affected by other mutations. No “true” spherocytes
were observed in 3D in c. d Patient with a mutation in band 3, mostly showing stomatocytes rather than spherocytes.
7Table I. Information on the tested hereditary spherocytosis patients.
Patient Mutated gene Corresponding Mutation Phenotypicalprotein defect
P1 SLC4A1 band 3 c.2423G>A (p.R808H) spectrin deficiency
P2 SLC4A1 band 3 c.2423G>A (p.R808H) spectrin deficiency
P3 not identified n.a. n.a. spectrin deficiency
P4 not identified n.a. n.a. spectrin deficiency
P5 ANK-1 ankyrin-1 c.2559-2A>G (splicing) predicted skipping of exon 26
and frameshift, loss
or truncated ankyrin
P6 SLC4A1 band 3 c.620delG (p.G207fs) loss or truncated band 3
P7 SLC4A1 band 3 c.2279G>A (p.R760Q) band 3 deficiency
P8 SLC4A1, band 3, c.2279G>A (p.R760Q) band 3 deficiency
SPTA1 spectrin c.3841C>T (p.R1281C)
and α LELY
P9 SLC4A1 band 3 c.163delC (p.H55TfsX11) band 3 deficiency
P10 SLC4A1 band 3 c.2510C>A (p.T837K) band 3 deficiency
8osmotic pressure
a b c
Figure 6. SDE training data were obtained by exposing RBCs from healthy donors to a different osmotic
pressure. In isotonic solution, most of the RBCs are discocytes, b. Upon decreasing the osmotic pressure (hypotonic
solution), the RBCs exhibit swelling and transform into stomatocytes and further into spherocytes, a. On the other
hand, echinocytes develop in hypertonic solution, c. Scale bar=2µm.
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